A Case of Pulmonary Actinomycosis Which Was Difficult to Clinically Differentiate from Lung Cancer Due to Elevated Serum CEA Levels
暂无分享,去创建一个
M. Kido | R. Nakanishi | S. Kuboi | K. Ozono | Masaaki Inoue
[1] C. Gemmell,et al. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. , 2005, The Journal of antimicrobial chemotherapy.
[2] N. Miyashita,et al. [Clinical analysis of pulmonary actinomycosis]. , 2005, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
[3] C. Kao,et al. Differentiating benign and malignant pulmonary lesions with FDG-PET. , 2001, Anticancer research.
[4] M. Seemann,et al. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. , 1999, Lung cancer.
[5] Mi Young Kim,et al. Thoracic actinomycosis: CT findings. , 1998, Radiology.
[6] J. Luketich,et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] N. Müller,et al. Thoracic actinomycosis: CT findings in eight patients. , 1992, Radiology.